Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Total Debt (2016 - 2025)

Bio-Techne (TECH) has 12 years of Total Debt data on record, last reported at $260.0 million in Q4 2025.

  • For Q4 2025, Total Debt fell 13.33% year-over-year to $260.0 million; the TTM value through Dec 2025 reached $260.0 million, down 13.33%, while the annual FY2025 figure was $346.0 million, 8.46% up from the prior year.
  • Total Debt reached $260.0 million in Q4 2025 per TECH's latest filing, down from $300.0 million in the prior quarter.
  • Across five years, Total Debt topped out at $447.0 million in Q4 2023 and bottomed at $200.0 million in Q4 2022.
  • Average Total Debt over 5 years is $313.4 million, with a median of $300.1 million recorded in 2021.
  • Peak YoY movement for Total Debt: plummeted 47.9% in 2021, then surged 123.5% in 2023.
  • A 5-year view of Total Debt shows it stood at $271.6 million in 2021, then decreased by 26.37% to $200.0 million in 2022, then surged by 123.5% to $447.0 million in 2023, then tumbled by 32.89% to $300.0 million in 2024, then fell by 13.33% to $260.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Debt were $260.0 million in Q4 2025, $300.0 million in Q3 2025, and $346.0 million in Q2 2025.